Tyme Technologies Inc.

(TYME) Trade

By |

Profile

Tyme Technologies Inc is the U.S based clinical-stage biotechnology company. The company is focused on the development and commercialization of targeted cancer therapeutics with a broad range of oncology indications for humans. SM 88, its proprietary drug candidate compound, is a novel compound that has the potential to alter defenses to oxidative stress and increase free radical availability to the cancer cell. The company is currently conducting a Phase II trial in prostate cancer.

Contact Information

Website: www.tymeinc.com
Email: arr@lifesciadvisors.com
Main Phone: +1 212 461-2315
Address: 17 State Street
Address 2: 7th Floor
State: NY
City / Town: New York
Country: USA
Postal Code: 10004

Issuer Information

Exchange: NSC
CEO: Steve Hoffman
Employees: 15
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

Tyme Technologies Inc is the U.S based clinical-stage biotechnology company. The company is focused on the development and commercialization of targeted cancer therapeutics with a broad range of oncology indications for humans. SM 88, its proprietary drug candidate compound, is a novel compound that has the potential to alter defenses to oxidative stress and increase free radical availability to the cancer cell. The company is currently conducting a Phase II trial in prostate cancer.

Contact Information

Website: www.tymeinc.com
Email: arr@lifesciadvisors.com
Main Phone: +1 212 461-2315
Address: 17 State Street
Address 2: 7th Floor
State: NY
City / Town: New York
Country: USA
Postal Code: 10004

Issuer Information

Exchange: NSC
CEO: Steve Hoffman
Employees: 15
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 1.23 $ -0.03 (-2.38%)
Last Price 1.23 Change $ -0.03 Change % -2.38 Tick N/A
Bid 1.21 Bid Size 400.00 Ask 1.35 Ask Size 1,000.00
Open 1.25 High 1.26 Low 1.23 Prev Close 1.26
Last Trade Volume 298,987 52 Wk Hi 4.64 52 Wk Low 0.92
Market Cap 137.7 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 111,950,937.00 EPS (TTM) -0.33 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 4 9
Number of Buys 0 0
Number of Sells 4 9
Net Activity -349438 -469724
Last 10 Buys Shares
N/A 0
Last 10 Sell Shares
Michael Demurjian 1,000
Steve Hoffman 1,000
Michael Demurjian 1,000
Steve Hoffman 1,000
Michael Demurjian 1,000
Steve Hoffman 1,000
Michael Demurjian 1,000
Steve Hoffman 1,000
Michael Demurjian 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 10 10 10 10
Low Target Price Estimate 7 7 7 7
Mean Target Price Estimate 8.83 8.83 8.83 8.83
Standard Deviation 1.61 1.61 1.61 1.61
Date of Most Recent Estimate 02/08/18 02/08/18 02/08/18 02/08/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 3 3 3
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1